Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-22

Clinical Trial Update: Faecal Microbiota Transplantation in Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial evaluating faecal microbiota transplantation for irritable bowel syndrome; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Faecal Microbiota Transplantation

Snippet

Sponsor: University College Cork | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN